1. Home
  2. TH vs SRPT Comparison

TH vs SRPT Comparison

Compare TH & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Hospitality Corp.

TH

Target Hospitality Corp.

HOLD

Current Price

$16.13

Market Cap

1.8B

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$15.77

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TH
SRPT
Founded
1978
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2017
2000

Fundamental Metrics

Financial Performance
Metric
TH
SRPT
Price
$16.13
$15.77
Analyst Decision
Strong Buy
Hold
Analyst Count
2
29
Target Price
$16.50
$25.85
AVG Volume (30 Days)
1.1M
3.6M
Earning Date
05-18-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.88
Revenue
$320,635,000.00
$2,198,237,000.00
Revenue This Year
$17.45
N/A
Revenue Next Year
$38.19
N/A
P/E Ratio
N/A
$5.51
Revenue Growth
N/A
15.58
52 Week Low
$5.97
$11.68
52 Week High
$20.85
$25.32

Technical Indicators

Market Signals
Indicator
TH
SRPT
Relative Strength Index (RSI) 35.60 35.98
Support Level $15.95 $15.55
Resistance Level $16.12 $18.16
Average True Range (ATR) 0.69 0.93
MACD -0.22 -0.35
Stochastic Oscillator 1.17 5.96

Price Performance

Historical Comparison
TH
SRPT

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services, including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. The company has three reportable segments: HFS - South, which provides specialty rental and hospitality services to the natural resources and development industry; WHS, which provides construction and hospitality solutions for critical mineral and data center projects; and Government, which provides specialty rental and hospitality services under government contracts.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: